Synbiotic supplementation improves symptoms in patients with post-COVID-19 chronic fatigue syndrome: results from a randomized placebo‑controlled clinical trial

Taking the synbiotic mixture for three months appeared to boost the body’s metabolism and mitigates some of the main symptoms of post-COVID fatigue syndrome.

Engineered gut bacteria may help deliver therapies

Engineered bacteria can be used in gut therapies, but maintaining control over their colonization and genetic stability remains challenging.

Bayer bets on biotics: new Darmstadt lab to fast-track microbiome-based health solutions

The next wave of gut health products won’t just claim to be natural — they’ll be microbiome-powered and science-certified.

Probiotics help counter harmful effects of high-sugar diets in mice

Probiotics protect against obesity and inflammation caused by high sugar intake, supporting their use as a preventive strategy for obesity-related diabetes.

Dietary fiber intake shapes gut microbiota activity and mucin degradation: insights from a human dietary intervention study

Mahesh Desai, group leader of the Eco-Immunology and Microbiome team at the Luxembourg Institute of Health and adjunct associate professor at the University of Southern Denmark, discusses about his research…

Danone opens OneBiome Lab at Paris-Saclay: where the microbiome meets AI

The race toward evidence-based microbiome nutrition has just found its new headquarters.

A mother’s oral microbes may shape her baby’s gut immunity and disease risk

Maternal oral microbiota plays a key role in influencing infant gut health and disease risk.

How exercise may change gut bacteria to help fight cancer

A recent study highlights formate as a potential target to boost cancer treatment.

ROELMI BIOTECH: a new production hub for precision biofermentation in Italy

The company is now taking a decisive step from laboratory-scale research to industrial-scale biofermentation.

Identifying the next targets in IBD: pathobionts and their clinical impact

Recent studies have identified various bacterial and fungal pathobionts in patients with CD and UC.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top